Pacific Biosciences of California, Inc. Cash and Cash Equivalents, Period Increase (Decrease)
Pacific Biosciences of California, Inc. (PACB) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$258.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-26.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2018-02-26
- Pacific Biosciences of California, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-12-31 was -$9.42M.
- Pacific Biosciences of California, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-09-30 was -$10.55M.
- Pacific Biosciences of California, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-06-30 was $7.50M, a 59.56% increase year-over-year.
- Pacific Biosciences of California, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-03-31 was $12.22M.
- Pacific Biosciences of California, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$258.00K.
- Pacific Biosciences of California, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$16.86M.
- Pacific Biosciences of California, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2015 was -$2.82M, a 127.96% decline from fiscal 2014.
- Pacific Biosciences of California, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2014 was $10.09M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2017-12-31 | -$9.42M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | -$19.97M derived: sum of 2 quarters · filed 2018-02-26 | -$12.47M derived: sum of 3 quarters · filed 2018-02-26 | -$258.00K 10-K · filed 2018-02-26 |
| 2017-09-30 | -$10.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | -$3.05M derived: sum of 2 quarters · filed 2017-11-02 | $9.17M 10-Q · filed 2017-11-02 | $3.14M derived: sum of 4 quarters · filed 2018-02-26 |
| 2017-06-30 | $7.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $19.71M 10-Q · filed 2017-08-02 | $13.68M derived: sum of 3 quarters · filed 2018-02-26 | $11.70M derived: sum of 4 quarters · filed 2018-02-26 |
| 2017-03-31 | $12.22M 10-Q · filed 2017-05-05 | $6.19M derived: sum of 2 quarters · filed 2018-02-26 | $4.20M derived: sum of 3 quarters · filed 2018-02-26 | $8.90M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-12-31 | -$6.03M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | -$8.01M derived: sum of 2 quarters · filed 2018-02-26 | -$3.31M derived: sum of 3 quarters · filed 2018-02-26 | -$16.86M 10-K · filed 2018-02-26 |
| 2016-09-30 | -$1.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $2.71M derived: sum of 2 quarters · filed 2017-11-02 | -$10.84M 10-Q · filed 2017-11-02 | -$4.41M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | $4.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | -$8.85M 10-Q · filed 2017-08-02 | -$2.43M derived: sum of 3 quarters · filed 2018-02-26 | -$1.15M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | -$13.55M 10-Q · filed 2017-05-05 | -$7.13M derived: sum of 2 quarters · filed 2018-02-26 | -$5.85M derived: sum of 3 quarters · filed 2018-02-26 | -$10.19M derived: sum of 4 quarters · filed 2018-02-26 |
| 2015-12-31 | $6.42M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $7.70M derived: sum of 2 quarters · filed 2018-02-26 | $3.36M derived: sum of 3 quarters · filed 2018-02-26 | -$2.82M 10-K · filed 2018-02-26 |
| 2015-09-30 | $1.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | -$3.06M derived: sum of 2 quarters · filed 2016-11-04 | -$9.24M 10-Q · filed 2016-11-04 | -$8.20M derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-06-30 | -$4.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$10.52M 10-Q · filed 2016-08-04 | -$9.48M derived: sum of 3 quarters · filed 2017-03-06 | -$2.27M derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-03-31 | -$6.18M 10-Q · filed 2016-05-05 | -$5.14M derived: sum of 2 quarters · filed 2017-03-06 | $2.07M derived: sum of 3 quarters · filed 2017-03-06 | -$10.99M derived: sum of 4 quarters · filed 2017-03-06 |
| 2014-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $8.25M derived: sum of 2 quarters · filed 2017-03-06 | -$4.81M derived: sum of 3 quarters · filed 2017-03-06 | $10.09M 10-K · filed 2017-03-06 |
| 2014-09-30 | $7.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$5.85M derived: sum of 2 quarters · filed 2015-11-05 | $9.05M 10-Q · filed 2015-11-05 | -$29.36M derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-06-30 | -$13.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $1.84M 10-Q · filed 2015-08-05 | -$36.57M derived: sum of 3 quarters · filed 2016-03-11 | -$12.63M derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-03-31 | $14.90M 10-Q · filed 2015-05-05 | -$23.51M derived: sum of 2 quarters · filed 2016-03-11 | $428.00K derived: sum of 3 quarters · filed 2016-03-11 | -$11.78M derived: sum of 4 quarters · filed 2016-03-11 |
| 2013-12-31 | -$38.41M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | -$14.47M derived: sum of 2 quarters · filed 2016-03-11 | -$26.68M derived: sum of 3 quarters · filed 2016-03-11 | -$20.18M 10-K · filed 2016-03-11 |
| 2013-09-30 | $23.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $11.73M derived: sum of 2 quarters · filed 2014-11-05 | $18.23M 10-Q · filed 2014-11-05 | $32.21M derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-06-30 | -$12.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | -$5.71M 10-Q · filed 2014-08-05 | $8.28M derived: sum of 3 quarters · filed 2015-03-12 | $7.21M derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-03-31 | $6.50M 10-Q · filed 2014-05-08 | $20.48M derived: sum of 2 quarters · filed 2015-03-12 | $19.41M derived: sum of 3 quarters · filed 2015-03-12 | -$3.22M derived: sum of 4 quarters · filed 2015-03-12 |
| 2012-12-31 | $13.98M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $12.92M derived: sum of 2 quarters · filed 2015-03-12 | -$9.72M derived: sum of 3 quarters · filed 2015-03-12 | -$12.32M 10-K · filed 2015-03-12 |
| 2012-09-30 | -$1.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$23.70M derived: sum of 2 quarters · filed 2013-11-12 | -$26.31M 10-Q · filed 2013-11-12 | -$25.02M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-06-30 | -$22.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$25.24M 10-Q · filed 2013-08-09 | -$23.96M derived: sum of 3 quarters · filed 2014-03-14 | -$20.89M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-03-31 | -$2.60M 10-Q · filed 2013-05-10 | -$1.32M derived: sum of 2 quarters · filed 2014-03-14 | $1.75M derived: sum of 3 quarters · filed 2014-03-14 | -$28.36M derived: sum of 4 quarters · filed 2014-03-14 |
| 2011-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $4.35M derived: sum of 2 quarters · filed 2014-03-14 | -$25.75M derived: sum of 3 quarters · filed 2014-03-14 | -$88.78M 10-K · filed 2014-03-14 |
| 2011-09-30 | $3.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | -$27.04M derived: sum of 2 quarters · filed 2012-11-01 | -$90.07M 10-Q · filed 2012-11-01 | -$5.14M derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-06-30 | -$30.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | -$93.14M 10-Q · filed 2012-08-07 | -$8.20M derived: sum of 3 quarters · filed 2013-03-15 | -$35.63M derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-03-31 | -$63.03M 10-Q · filed 2012-05-07 | $21.90M derived: sum of 2 quarters · filed 2013-03-15 | -$5.53M derived: sum of 3 quarters · filed 2013-03-15 | |
| 2010-12-31 | $84.93M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $57.51M derived: sum of 2 quarters · filed 2013-03-15 | $58.42M 10-K · filed 2013-03-15 | |
| 2010-09-30 | -$27.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | -$26.52M 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $912.00K 10-Q · filed 2011-08-12 | |||
| 2009-12-31 | $10.77M 10-K · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |